Research & Development
Policy & Regulation
Trends & Finance
Collaboration: Page 2
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Oxford Nanopore, IQVIA form nanopore sequencing partnership
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
CrisprBits, MolBio Diagnostics to collaborate on POC tests
The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.
August 23, 2023
Visiopharm, Boston Cell Standards team up to support higher assay requirements
If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.
August 17, 2023
Amoy Diagnostics, AstraZeneca partner on CDx for lung cancer therapy
This agreement is the latest in ongoing collaborations to develop and commercialize AmoyDx assays for companion diagnostic use with AstraZeneca's prostate, breast, and ovarian cancer therapies.
August 16, 2023
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Illumina inks deal to sell Pillar Biosciences’ cancer assays
Pillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.
July 26, 2023
AccuStem Sciences and EmeritusDX team up on breast cancer assay, product portfolio
Initially, the partnership will focus on furthering the validation of StemPrintER, AccuStem’s recurrence predictor assay for patients with breast cancer.
July 19, 2023
MGI Tech, Xpress Genomics partner on sequencing technologies
The agreement is aimed at developing scalable solutions that combine Xpress Genomics’ deep single-cell RNA sequencing expertise with MGI's automation and sequencing technologies.
June 14, 2023
MGI Tech, AddLife announce Nordic regional distribution agreement
Under the agreement, AddLife will distribute MGI Tech’s products through its four Triolab Group subsidiaries: Triolab Sweden, Triolab Norway, Triolab Denmark (Iceland), and Triolab Finland. The subsidiaries will act as separate distributors.
June 12, 2023
Page 2 of 38